Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF
Related Posts
Chitsazan M, Parekh JK, Grundmann AL, Lau ES, Alotaibi M, Yu B, Rebholz CM, Selvin E, Allen NB, Allison MA, Jain M, Cheng S, Ho[...]
Echouffo-Tcheugui JB, Liu X, Soliman EZ, Pi-Sunyer X, Golden SH, Dagogo-Jack S, White NH, Budoff M, Ibebuogu U, Darwin C, Knowler WC, Temprosa M; DPP[...]
Brownell NK, Inkelas M, Chen L, Leng M, Doan AAQ, Shannon E, Jackson N, Hsue P, Ong M, Yano E, Fonarow GC, Ziaeian B. Healthcare[...]